|
US7731972B1
(en)
*
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
WO1999022763A2
(en)
*
|
1997-10-31 |
1999-05-14 |
Cistron Biotechnology, Inc. |
Encapsulated immunomodulators useful as vaccine adjuvants
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
WO2002038175A1
(en)
*
|
2000-11-07 |
2002-05-16 |
Immunovaccine Technologies Inc. |
Vaccines with enhanced immune response and methods for their preparation
|
|
AU3652602A
(en)
*
|
2000-11-15 |
2002-05-27 |
Us Gov Health & Human Serv |
Sol-fusin: use of gp64-6his to catalyze membrane fusion
|
|
MY134424A
(en)
*
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
|
EP1404298A2
(en)
*
|
2001-06-25 |
2004-04-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
A method for preparation of vesicles loaded with biological material and different uses thereof
|
|
ATE431745T1
(de)
*
|
2001-07-05 |
2009-06-15 |
Ltb4 Sweden Ab |
Ltb4 als adjuvans für impfstoffe
|
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
CN1665487A
(zh)
*
|
2002-07-03 |
2005-09-07 |
埃弗顿有限公司 |
脂质体疫苗
|
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
CA2523413A1
(en)
|
2003-04-25 |
2004-11-11 |
The Penn State Research Foundation |
Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
|
|
US20060286161A1
(en)
*
|
2003-05-09 |
2006-12-21 |
Steffen Panzner |
Injectable liposomal depots for delivering active ingredients
|
|
EP1666059A4
(en)
*
|
2003-08-11 |
2008-08-27 |
Univ Osaka Res Found |
NEW VACCINE WITH AN ADJUVANS FOR TRIGGERING ABSORBENT IMMUNITY
|
|
JP4970035B2
(ja)
*
|
2003-08-21 |
2012-07-04 |
リポテック・プロプライエタリー・リミテッド |
ｉｎｖｉｖｏにおける樹状細胞の標的化
|
|
FR2868951B1
(fr)
*
|
2004-04-15 |
2006-07-21 |
Ethypharm Sa |
Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
|
|
US20050260260A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Edward Kisak |
Liposome compositions for the delivery of macromolecules
|
|
WO2006074303A2
(en)
*
|
2005-01-05 |
2006-07-13 |
Philadelphia Health And Education Corporation |
Delivery vehicles, bioactive substances and viral vaccines
|
|
CA2523032A1
(en)
*
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
CN106310293A
(zh)
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
WO2009090650A2
(en)
*
|
2008-01-16 |
2009-07-23 |
Ben-Gurion University Of The Negev Research And Development Authority |
Vaccine for alzheimer's disease
|
|
AU2009253780B2
(en)
|
2008-06-05 |
2014-08-14 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
CA2730340C
(en)
|
2008-07-14 |
2017-02-07 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
WO2010086864A1
(en)
|
2009-02-02 |
2010-08-05 |
Galmed International Ltd. |
Methods and compositions for treating alzheimer's disease
|
|
WO2011005772A1
(en)
|
2009-07-06 |
2011-01-13 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
AU2010270722B2
(en)
|
2009-07-06 |
2015-06-04 |
Variation Biotechnologies, Inc. |
Methods for preparing vesicles and formulations produced therefrom
|
|
WO2011007353A1
(en)
|
2009-07-14 |
2011-01-20 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
CN102665755A
(zh)
|
2009-10-09 |
2012-09-12 |
纽约血库公司 |
与免疫增强剂相连的寡聚流感免疫原性组合物
|
|
CA2783001C
(en)
|
2010-01-19 |
2017-12-12 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
|
CA2840079C
(en)
*
|
2010-07-06 |
2018-07-03 |
Variation Biotechnologies Inc. |
Compositions and methods for treating influenza
|
|
MX359103B
(es)
|
2011-01-13 |
2018-09-14 |
Variation Biotechnologies Inc |
Composiciones y sus usos en el tratamiento de infecciones virales.
|
|
MX357319B
(es)
|
2011-01-13 |
2018-07-04 |
Variation Biotechnologies Inc |
Metodo para preparar vesiculas y formulaciones producidas de las mismas.
|
|
IN2014CN02581A
(enExample)
|
2011-10-06 |
2015-08-07 |
Immunovaccine Technologies Inc |
|
|
CA2890084C
(en)
|
2011-11-18 |
2021-05-04 |
Maura Ellen Campbell |
Synthetic derivatives of mpl and uses thereof
|
|
US20140356399A1
(en)
|
2012-01-12 |
2014-12-04 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
CA2894467A1
(en)
|
2012-01-27 |
2013-08-01 |
Variation Biotechnologies Inc. |
Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents
|
|
CN103736090B
(zh)
*
|
2014-01-27 |
2016-03-02 |
中国医学科学院医学生物学研究所 |
甲磺酸去铁胺佐剂及含甲磺酸去铁胺佐剂的疫苗
|
|
CN110151702A
(zh)
*
|
2019-06-24 |
2019-08-23 |
昆明医科大学 |
聚乙二醇修饰流感疫苗脂质体及其制备方法
|